RhumbLine Advisers’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-113,431
| Closed | -$1.09M | – | 4185 |
|
|
2024
Q4 | $1.09M | Buy |
113,431
+8,931
| +9% | +$85.7K | ﹤0.01% | 2211 |
|
|
2024
Q3 | $299K | Buy |
104,500
+7,488
| +8% | +$21.4K | ﹤0.01% | 3028 |
|
|
2024
Q2 | $283K | Buy |
97,012
+3,875
| +4% | +$11.3K | ﹤0.01% | 3034 |
|
|
2024
Q1 | $297K | Buy |
93,137
+3,955
| +4% | +$12.6K | ﹤0.01% | 2984 |
|
|
2023
Q4 | $300K | Buy |
89,182
+1,985
| +2% | +$6.67K | ﹤0.01% | 2973 |
|
|
2023
Q3 | $208K | Sell |
87,197
-4,964
| -5% | -$11.8K | ﹤0.01% | 3142 |
|
|
2023
Q2 | $162K | Buy |
+92,161
| New | +$162K | ﹤0.01% | 3341 |
|
|
2022
Q2 | – | Sell |
-34,064
| Closed | -$153K | – | 3264 |
|
|
2022
Q1 | $153K | Buy |
34,064
+3,137
| +10% | +$14.1K | ﹤0.01% | 2816 |
|
|
2021
Q4 | $211K | Sell |
30,927
-516
| -2% | -$3.52K | ﹤0.01% | 2820 |
|
|
2021
Q3 | $229K | Buy |
31,443
+982
| +3% | +$7.15K | ﹤0.01% | 2861 |
|
|
2021
Q2 | $305K | Buy |
30,461
+8,301
| +37% | +$83.1K | ﹤0.01% | 2778 |
|
|
2021
Q1 | $212K | Buy |
22,160
+11,818
| +114% | +$113K | ﹤0.01% | 2819 |
|
|
2020
Q4 | $113K | Buy |
+10,342
| New | +$113K | ﹤0.01% | 2955 |
|